AGL (Agilon Health) Moat Score: 4/10 (As of Jul. 03, 2026)


AGL Agilon Health Inc AGL
74 GF Score
Price $111.01
GF Value $94.42
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Agilon Health Moat Score?

Agilon Health AGL -0.65% 74 Moat Score is 4 as of Jul. 03, 2026. GuruFocus rates AGL with a GF Score™ of 74/100 and a GF Value™ of $94.42 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 679 Healthcare Providers & Services companies, Agilon Health ranks better than 89.69% on this metric.

Agilon Health has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

Agilon Health has Narrow Moat: Agilon Health benefits from a discernible but modest moat through its network effects and customer switching costs in healthcare services. However, it lacks strong brand strength and durable cost advantages, limiting its competitive edge.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Agilon Health might have Narrow Moat - Discernible but modest moat.

Agilon Health  (NYSE:AGL) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Agilon Health Moat Score Related Terms

AGL vs MD, SEM, SGRY: Moat Score Comparison

For the Medical Care Facilities subindustry, Agilon Health's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Agilon Health Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Agilon Health's Moat Score distribution charts can be found below:

* The bar in red indicates where Agilon Health's Moat Score falls into.


AGL
74GF Score
Agilon Health Inc AGL
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
Agilon Health (AGL) has a Moat Score of 4 as of Jul. 03, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Agilon Health ranks #70 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 10.3%.
Is Agilon Health's Moat Score too high?
Agilon Health's current Moat Score is 4. Based on the distribution chart, Agilon Health ranks #70 out of 679 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Agilon Health has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Agilon Health's Moat Score compare to MD and SEM?
According to the Healthcare Providers & Services industry distribution chart, Agilon Health ranks #70 out of 679 companies for Moat Score. This places Agilon Health in the top 10% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Agilon Health's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilon Health stock overvalued right now?
Based on GuruFocus' analysis, Agilon Health (AGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $94.42, compared to a current price of $111.01 — trading 17.6% above its estimated fair value. The current Moat Score is 4. Agilon Health's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Agilon Health (AGL), the current Moat Score is 4 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Agilon Health (AGL) Overvalued in 2026?

Based on GuruFocus' analysis, Agilon Health stock appears to be overvalued. The current stock price of $111.01 is trading 17.6% above its estimated GF Value™ of $94.42. GuruFocus considers Agilon Health to be Modestly Overvalued.

Key valuation signals for AGL:

  • Moat Score: 4
  • GF Value™: $94.42 vs. price of $111.01 (17.6% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the AGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Agilon Health Business Description

Address 440 Polaris Parkway, Suite 550, Westerville, OH, USA, 43082
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
74GF Score

Get the complete analysis for AGL

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$111.01
Price
$94.42
GF Value